4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000029
Director sold 7,497 shares at $25.90 ($194,172)
- Director acquired 15,933 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,933 | 156,717 | D | ||
| 2025-04-10 | Sale : show line 2 in the form 10b5-1 | −7,497 | $25.90 | $194,172 | 149,220 | D |
| Open-market sales · 7,497 sh · avg $25.90 · $194,172 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-04-08 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −15,933 | 0 | D |
Loading xslF345X05/wk-form4_1744315371.xml…